Q2 results: Pfizer reports 52.11 percent decline in net profit at Rs 148.96 crore
New Delhi: Drug firm Pfizer Ltd has reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023.
The company had logged a net profit of Rs 311.07 crore in July-September period a year ago, according to a regulatory filing by Pfizer.
Revenue from operations declined 9.76 per cent to Rs 575.21 crore in the quarter as against Rs 637.47 crore in the year-ago period.
Read also: USFDA nod for Pfizer Meningococcal vaccine Penbraya
Total expense was at Rs 410.76 crore, down 5.66 per cent.
Total income was at Rs 611.28 crore in September quarter 2023-24, down 7.62 per cent.
Read also: Pfizer gains unconditional EU antitrust nod for proposed USD 43 billion Seagen acquisition
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd